Search
Search Constraints
You searched for: Author/Creator Kuriyakose, Sherine O.- Kuriyakose, Sherine O. [remove] 6
- 615.372 6
- Vaccines -- Periodicals 6
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- CPS capsular polysaccharide -- DTaP-HepB-IPV/Hib diphtheria-tetanus-acellular pertussis-hepatitis B virus-inactivated poliovirus and Haemophilus influenzae type b vaccine -- ECL electrochemiluminescence -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- HBs hepatitis B surface antigen -- GMC geometric mean concentration -- GMT geometric mean titer -- Hib Haemophilus influenzae type b -- LLoQ lower limit of quantitation -- PCV13 13-valent pneumococcal conjugate vaccine -- PRN pertactin -- PRP polyribosylribitol phosphate -- PT pertussis toxoid -- RCT randomized controlled trial -- SAE serious adverse event -- Tdap diphtheria-tetanus-acellular pertussis vaccine -- TVC total vaccinated cohort 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- CPS capsular polysaccharide -- DTaP-HepB-IPV/Hib diphtheria-tetanus-three-component acellular pertussis-hepatitis B virus-inactivated poliovirus/Haemophilus influenzae type b vaccine -- DU D antigen units -- ECL electrochemiluminescence -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- GMC geometric mean concentration -- GMT geometric mean titer -- HBs hepatitis B surface antigen -- Hib Haemophilus influenzae type b -- IPV inactivated poliovirus -- IU international units -- PCV13 13-valent pneumococcal conjugate vaccine -- PRN pertactin -- PRP polyribosylribitol phosphate -- PT pertussis toxoid -- SAE serious adverse event -- Tdap tetanus-reduced-antigen-content diphtheria-acellular pertussis vaccine -- TT tetanus toxoid -- TVC total vaccinated cohort -- UK United Kingdom -- US United States -- WHO World Health Organization 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- DTPa combined diphtheria-tetanus toxoids-acellular pertussis vaccine -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- GMC geometric mean concentration -- IU international units -- LL lower limit -- PRN pertactin -- PT pertussis toxoid -- SAE serious adverse event -- Tdap combined vaccine containing reduced-antigen-content of diphtheria toxoid, tetanus toxoid, and acellular pertussis -- US United States 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- ELISA enzyme-linked immunosorbent assays -- FHA filamentous hemagglutinin -- GMC geometric mean concentration -- ICF informed consent form -- LL lower limit -- LLoQ lower limit of quantitation -- PRN pertactin -- PT pertussis toxoid -- SAE serious adverse event -- Tdap diphtheria-tetanus-acellular pertussis vaccine -- TVC total vaccinated cohort -- UK United Kingdom -- US United States 1
- DTPa-IPV/Hib -- acellular pertussis -- diphtheria -- tetanus -- poliovirus Haemophilus influenzae type b -- pediatric population -- immunogenicity -- safety -- reactogenicity 1
- Reduced-antigen-content diphtheria–tetanus–acellular pertussis vaccine -- Persistence -- Booster immunization -- Adults 1
- Tdap -- Adult formulation acellular pertussis vaccine -- Maternal immunization 1
- Tdap vaccine -- Pertussis -- Maternal immunization -- Blunting -- Infants 1